A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma

Condition:   Asthma
Interventions:   Drug: Fluticasone Propionate MDPI;   Drug: Fluticasone Propionate/Salmeterol MDPI;   Drug: Fluticasone propionate/salmeterol
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified February 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.